Norges Bank’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$1.55M Buy
2023
Q1
Sell
2022
Q4
$1.48M Buy
2022
Q3
$216K Hold
2022
Q2
$147K Buy
2020
Q4
Sell
2020
Q3
$269K Sell
2020
Q2
$1.13M Buy